Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Sukumar Mukherjee"'
Autor:
Keerthi Talari, Vinod Ravindran, Pradip Kumar, Pravin Patil, Sarath Chandra Mouli, Syamasis Bandyopadhyay, Balebail G Dharmanand, Abhrajit Ray, Shankaralingam Rajeshwari, Sanjiv N Amin, Jyotsna Oak, Ved Chaturvedi, Anand N Malaviya, Sukumar Mukherjee
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 3, Pp 311-321 (2021)
Pharmacological management of rheumatoid arthritis (RA) includes synthetic and biological disease-modifying antirheumatic drugs (DMARDs). Biological DMARDs, also referred to as “biologics,” rapidly retard progression of the joint damage seen in R
Externí odkaz:
https://doaj.org/article/8afbed8558ee4037a7ddc3fa0f34c61f
Autor:
Pradip Kumar Sarma, Sukumar Mukherjee, R N Sarkar, Santosh Kumar Mandal, Pradeepta Patra, Tanoy Bose, Ajit Surin, Santa Naorem, Kaushik Basu, J.R. Parida, CT Arunachalam
Publikováno v:
International Journal of Medical Research and Review; Vol 10 No 4 (2022): Jul-Aug; 113-121
Introduction: Owing to dearth of data on infliximab biosimilars in Indian patients, a pan-India case database-based study with infliximab biosimilar BOW015 (Infimab™) was carried out to capture its efficacy and safety in real world clinical setting
Autor:
Sarath Chandra Mouli, Keerthi Talari, Abhrajit Ray, Syamasis Bandyopadhyay, Balebail G. Dharmanand, Anand N. Malaviya, Shankaralingam Rajeshwari, Sanjiv Amin, Sukumar Mukherjee, Pradip Kumar, Pravin Patil, Vinod Ravindran, V K Chaturvedi, Jyotsna Oak
Publikováno v:
Indian Journal of Rheumatology, Vol 16, Iss 3, Pp 311-321 (2021)
Pharmacological management of rheumatoid arthritis (RA) includes synthetic and biological disease-modifying antirheumatic drugs (DMARDs). Biological DMARDs, also referred to as “biologics,” rapidly retard progression of the joint damage seen in R
Autor:
Rajeev Chawla, Gurpreet S. Wander, Sandhya A Kamath, Mrinal Kanti Das, Vivekanand Jha, Banshi Saboo, Aspi R. Billimoria, Rajan Sharma, Siddharth N Shah, Kewal C. Goswami, Y P Munjal, Ragini Rohatgi, M. Maiya, Hardik Shah, Nihar Mehta, Sukumar Mukherjee, Ashok Kirpalani, Pritam Gupta, Mohan Rajapurkar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::143fa0f5bc65eb741fdc97428bb8cb42
https://ora.ox.ac.uk/objects/uuid:e3234c14-7c90-4986-9c66-677dc46c42f1
https://ora.ox.ac.uk/objects/uuid:e3234c14-7c90-4986-9c66-677dc46c42f1
Autor:
Sukumar Mukherjee, Pampita Chakraborty
Publikováno v:
International Journal of Current Microbiology and Applied Sciences. 5:920-925
Publikováno v:
The Indian Journal of Medical Research
Indian Journal of Medical Research, Vol 152, Iss 5, Pp 456-467 (2020)
Indian Journal of Medical Research, Vol 152, Iss 5, Pp 456-467 (2020)
Biosimilars or similar biotherapeutic products are the biological products approved by regulatory agencies based on the demonstration of similarity in quality, safety and efficacy with reference biologics (or original biologics). Though biosimilars c
Autor:
Sukumar Mukherjee, Alakendu Ghosh
Publikováno v:
Rheumatology Principles and Practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::22b87d8de83f61c244d7bfc2041959a0
https://doi.org/10.5005/jp/books/11169_26
https://doi.org/10.5005/jp/books/11169_26
Autor:
Sukumar Mukherjee
Publikováno v:
Medicine Update (Volume 17, 2007)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e3097f72ac0c0b3398bb20a4b7577f88
https://doi.org/10.5005/jp/books/12086_2
https://doi.org/10.5005/jp/books/12086_2
Autor:
Sukumar, Mukherjee
Publikováno v:
The Journal of the Association of Physicians of India.
Autor:
Sukumar, Mukherjee, Alakendu, Ghosh
Publikováno v:
The Journal of the Association of Physicians of India.